|
1. Chastain DB, Covert KL, Tu PJ, McDougal S, White BP, Cluck D. Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Narrative Review. Ann Pharmacother. 2023;57(11):1312–27.
2. Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary Management of Staphylococcus aureus Bacteremia - Controversies in Clinical Practice. Clin Infect Dis. 2023;77(11):e57–68.
3. Kouijzer IJE, Fowler VG, ten Oever J. Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management. J Infect. 2023;86(1):9–13.
4. López-Cortés LE, Gálvez-Acebal J, Rodríguez-Baño J. Therapy of Staphylococcus aureus bacteremia: Evidences and challenges. Enferm Infecc Microbiol Clin. 2020;38(10):489–97.
5. Holubar M, Meng L, Alegria W, Deresinski S. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Infect Dis Clin North Am. 2020;34(4):849–61.
6. Tabah A, Laupland KB. Update on Staphylococcus aureus bacteraemia. Curr Opin Crit Care. 2022;28(5):495–504.
7. Davis JS, Petersiel N, Tong SYC. How I manage a patient with MRSA bacteraemia. Clin Microbiol Infect. 2022;28(2):190–4.
8. Legg A, Davis JS, Roberts JA. Optimal drug therapy for Staphylococcus aureus bacteraemia in adults. Curr Opin Crit Care. 2023;29(5):446–56.
9. Rivera ES, Gentil PR, Baño JR. Guia de antibioterapia Hospital Universitario Virgen Macarena. 2024
|
